STOCK TITAN

EVELO BIOSCIENCES INC (EVLO) Net Income by Year

EVLO

EVELO BIOSCIENCES INC reported a net loss of $114.5M in fiscal year 2022. This represents an increase of 6.3% from the prior fiscal year. The table below carries 7 fiscal years, from 2016 to 2022, and the quarters EVELO BIOSCIENCES INC has filed alongside them.

FY2022 annual
Net Income -$114.5M
YoY +6.3%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2023, ended Sep 30, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EVLO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income-$114.5M+6.3%-$122.2M-30.4%-$93.7M-9.6%-$85.5M-50.1%-$56.9M-103.0%-$28.0M-110.4%-$13.3M

EVLO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-QQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-K
Net Income-$12.4M+59.5%-$21.1M+30.9%-$25.3M+15.1%N/A-$30.6M+9.4%-$30.6M+3.3%-$29.9M-5.9%N/A-$33.7M-61.2%-$31.6M-53.0%-$28.2M-22.4%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More EVELO BIOSCIENCES INC financials

Frequently Asked Questions

What was EVELO BIOSCIENCES INC's net income in fiscal year 2022?

EVELO BIOSCIENCES INC reported a net loss of $114.5M in fiscal year 2022.

How fast is EVELO BIOSCIENCES INC's net income growing?

EVELO BIOSCIENCES INC (EVLO) net income rose by 6.3% year over year, from -$122.2M to -$114.5M in fiscal year 2022.

How has EVELO BIOSCIENCES INC's net income changed over the years?

Across the 7 fiscal years this page covers, EVELO BIOSCIENCES INC (EVLO) net income went from -$13.3M in fiscal year 2016 to -$114.5M in fiscal year 2022.

EVELO BIOSCIENCES INC (EVLO) reported -$12.4M in net income in Q3 2023. This represents an increase of 59.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what EVELO BIOSCIENCES INC (EVLO) reported on that line in every period on record.